| Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κ B activation O Moiseeva, X Deschênes‐Simard, E St‐Germain, S Igelmann, G Huot, ... Aging cell 12 (3), 489-498, 2013 | 546 | 2013 |
| The senescence-associated secretory phenotype and its regulation S Lopes-Paciencia, E Saint-Germain, MC Rowell, AF Ruiz, P Kalegari, ... Cytokine 117, 15-22, 2019 | 400 | 2019 |
| Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway F Lessard, S Igelmann, C Trahan, G Huot, E Saint-Germain, L Mignacca, ... Nature cell biology 20 (7), 789-799, 2018 | 113 | 2018 |
| SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes E Saint-Germain, L Mignacca, M Vernier, D Bobbala, S Ilangumaran, ... Aging (Albany NY) 9 (10), 2137, 2017 | 88 | 2017 |
| Circumventing senescence is associated with stem cell properties and metformin sensitivity X Deschênes‐Simard, M Parisotto, MC Rowell, B Le Calvé, S Igelmann, ... Aging cell 18 (2), e12889, 2019 | 38 | 2019 |
| Sponges against miR-19 and miR-155 reactivate the p53-Socs1 axis in hematopoietic cancers L Mignacca, E Saint-Germain, A Benoit, V Bourdeau, A Moro, G Ferbeyre Cytokine 82, 80-86, 2016 | 35 | 2016 |
| CHES1/FOXN3 regulates cell proliferation by repressing PIM2 and protein biosynthesis G Huot, M Vernier, V Bourdeau, L Doucet, E Saint-Germain, ... Molecular biology of the cell 25 (5), 554-565, 2014 | 31 | 2014 |
| Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex N Del Toro, A Fernandez-Ruiz, L Mignacca, P Kalegari, MC Rowell, ... Cell Cycle 18 (6-7), 759-770, 2019 | 22 | 2019 |
| Phosphorylation of SOCS1 Inhibits the SOCS1–p53 Tumor Suppressor Axis E Saint-Germain, L Mignacca, G Huot, M Acevedo, K Moineau-Vallée, ... Cancer research 79 (13), 3306-3319, 2019 | 21 | 2019 |
| SOCS1: phosphorylation, dimerization and tumor suppression F Lessard, E Saint-Germain, L Mignacca, G Ferbeyre Oncoscience 6 (11-12), 386, 2019 | 9 | 2019 |
| Tumor suppressor activity of the ERK/MAPK signaling: inhibition of cell reprogramming by degradation of specific proteins X Deschênes-Simard, F Kottakis, F Lessard, E Saint-Germain, ... Cancer Research 74 (19 Supplement), 3895-3895, 2014 | 2 | 2014 |
| ERK/MAPK pathway inhibits tumorigenesis and cellular reprogramming of pancreatic cancer cells B le Calvé, X Deschenes-Ximard, F Kottakis, V Bourdeau, F Lessard, ... Cancer Research 75 (15 Supplement), 2154-2154, 2015 | 1 | 2015 |
| Mécanismes moléculaires de régulation de l’interaction SOCS1-p53 et leurs impacts sur la suppression tumorale E Saint-Germain | | 2018 |
